Skip to main navigation Skip to search Skip to main content

Oral versus intravenous fluoropyrimidines for metastatic colorectal cancer

  • Andrew Strickland*
  • , Peter Harper
  • , Christos Karapetis
  • , Christopher B. Steer
  • , Desmond Yip
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Oral versus intravenous fluoropyrimidines for metastatic colorectal cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science